Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer
Related Research units
Abstract
CD151 belongs to the group of tetraspanins and is aberrantly expressed in different tumours and differential expression has been associated with prognosis. The aim of this study was to clarify the relationship of CD151 expression with tumour phenotype and clinical outcome in bladder cancer.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 5 |
| ISSN | 0031-3025 |
| DOIs | |
| Publication status | Published - 08.2012 |
